Genitourinary Cancer
News
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
Clinical Topics & News
Concurrent Romiplostim With FOLFIRINOX for Secondary Prevention of Thrombocytopenia in a Patient With Myelodysplastic Syndrome and Pancreatic Adenocarcinoma
News
The ‘great dynamism’ of radiation oncology
Highlights from this research reveal how high-tech radiotherapy, such as hypofractionation and stereotactic body radiotherapy, has improved care...
News
Annual PSA screening important for Black men
“Given that Black men are younger at diagnosis and have worse prostate cancer survival compared with White men,” more intensive screening...
Article
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single Center
This research sought to determine whether veterans with hepatocellular carcinoma experienced disparities in care in terms of stage at diagnosis,...
News
Blood test could provide insight into patients’ metastatic cancer
“Our research significantly expands the breadth of cancer information that can be obtained from only a few drops of blood.”
News
Quality of life benefit exaggerated in some cancer studies
News
Cancer may increase risk of type 2 diabetes
Study demonstrates elevated risk of developing diabetes for people with lung, pancreatic, breast, brain, urinary tract, or uterine cancers